Many people who rely on power wheelchairs to get around will soon have the option to let onboard AI negotiate obstacles, adjust speeds and avoid collisions. 

Improving care for patients with cardiac amyloidosis has emerged as one of the hottest topics in cardiology. Pfizer helped kickstart that trend in 2019 when it gained FDA approval for two separate medications for the rare, but potentially fatal disease. 

In 2018, almost a quarter of surveyed Americans expected healthcare to be among the earliest and hardest hit of all employment sectors. However, in 2023, McKinsey & Co. projected overall demand for healthcare workers to grow by 30% by 2030.

For AI to achieve sweeping adoption across U.S. medicine, physicians will need to be assured they won’t be held liable should clinical algorithms make mistakes.

Americans aren’t OK with generative healthcare AI that was developed without physicians and is sold by vendors without track records. 

Cardiology makes up 10% of the 692 market-cleared clinical AI algorithms in the FDA’s latest update on the number of patient-facing AI now commercialized in the U.S. Experts share their thoughts on how it is being used.

Medical imaging makes up 76% of all the FDA-cleared artificial intelligence clinical algorithms used for direct patient care.

Rad Partners' Nina Kottler, MD, explains what practices should consider when assessing artificial intelligence solutions in an era where there is little reimbursement.